Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 439.0 | 79 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 444.0 | 76 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 356.5 | 86 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 442.0 | 77 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 452.0 | 70 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | IL-1B | 441.5 | 58 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 474.0 | 65 | |
N2645 | TNF-a | 100 | ng/mL | 2 | IL-1B | 392.0 | 77 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-1B | 479.5 | 82 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | IL-1B | 462.0 | 64 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 27.0 | 83 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 22.0 | 87 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 15.5 | 80 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 22.0 | 72 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 61.0 | 82 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 22.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 90.0 | 82 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 81.5 | 84 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 45.0 | 73 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 57.0 | 73 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 91.5 | 78 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL-1B | 93.0 | 51 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 23.0 | 79 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 22.0 | 81 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 17.0 | 82 |